SCHEMBL19135757

SCHEMBL19135757

CN1CCN(c2ncc(N3CCC(Cc4ccccc4)CC3)cn2)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.53
SLC6A4 P31645 4/20 0.53
TSHR P16473 3/20 0.53
SMN1; SMN2 Q16637 4/20 0.51
ALK Q9UM73 1/20 0.51
MAPT P10636 5/20 0.50
LMNA P02545 2/20 0.50
HTT P42858 2/20 0.50
ALDH1A1 P00352 1/20 0.50
HTR3A P46098 1/20 0.48
HRH4 Q9H3N8 1/20 0.48
NPC1 O15118 1/20 0.47
STAT3 P40763 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47
PRMT6 Q96LA8 2/20 0.47
CCR3 P51677 1/20 0.47
HTR1A P08908 1/20 0.46
HTR1D P28221 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8119586 0.80 TSHR (0.64) TSHRSMN1; SMN2MAPTLMNAHTT
SCHEMBL327856 0.78 CCR3 (0.66) PRMT6CCR3CARM1
SCHEMBL22340469 0.77 SMN1; SMN2 (0.54) SLC6A2SLC6A4TSHRSMN1; SMN2MAPT
SCHEMBL7241082 0.76 SLC6A2 (0.71) SLC6A2SLC6A4TSHRSMN1; SMN2MAPT
SCHEMBL10502431 0.74 TSHR (0.54) TSHRSMN1; SMN2MAPTLMNANPC1
SCHEMBL3436965 0.73 PRMT6 (0.62) SLC6A2SLC6A4PRMT6CCR3CARM1
SCHEMBL14503465 0.72 TSHR (0.74) TSHRSMN1; SMN2MAPTLMNAHTT
SCHEMBL22324836 0.71 SMN1; SMN2 (0.50) SLC6A2SLC6A4TSHRSMN1; SMN2MAPT
SCHEMBL3540368 0.70 SLC6A2 (0.63) SLC6A2SLC6A4TSHRSMN1; SMN2MAPT
SCHEMBL5596598 0.70 TSHR (0.56) TSHRSMN1; SMN2MAPTLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9708305-B2 Substituted 1,2,3,4-tetrahydroisoquinoline derivatives for the treatment of hormone-dependent diseases UNIVERSITé LAVAL (CA) 2017-07-18 US disclosed